Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFD Technologies Regulatory News (FDP)

  • This share is currently suspended. It was suspended at a price of 2,450.00
  • There is currently no data for FDP

Acquisition

15 Sep 2008 07:00

RNS Number : 3928D
First Derivatives PLC
15 September 2008
 

15 September 2008

First Derivatives plc 

(AIM:FDP.L, IEX:GYQ.I)

Acquisition of Market Resource Partners

The Board of First Derivatives plc ("First Derivatives" or the "Company") announces that it has acquired Market Resource Partners LLC ("MRP"), a US based technology marketing company headquartered in Philadelphia, PA, for a total consideration of up to $20 million (£11.3m) (the "Acquisition"). The Acquisition comprises an initial cash payment of $4.5m (£2.5m) and a further $1.5m (£0.8m) through the issue of 436,644 First Derivatives new ordinary shares (the "Consideration Shares"). An additional deferred consideration of up to a maximum of $14m (£7.9m) (will be payable, subject to MRP achieving certain profit goals during the two years ending 31 August 2010. The initial cash consideration will be financed from the Company's existing bank facilities.

Founded in 2002, MRP specializes in the strategic development and tactical execution of marketing and sales programs for software and technology service firms. Utilizing MRP's strategic consulting and predictive analytics, clients are in a position to make more informed decisions leading to immediate and longer term sales opportunities. MRP's clients comprise technology firms, Independent Software Vendors and channel resellers including Microsoft, Sun Microsystems and Cisco Systems. MRP employs 95 people in its office in Philadelphia, PA.

MRP achieved an EBITDA of $838,000 (£474,000) in the 12 months to 31 December 2006 and EBITDA of $335,000 (£190,000) in the 12 months to 31 December 2007 after adjusting for one-off costs of $163,000 (£92,000) from relocating their head office. In the six months to 30 June 2008 MRP achieved EBITDA of $653,000 (£369,000). The vendors have warranted that MRP's net assets as at 31 August 2008 (the effective date of the transaction) were not less than $200,000 (£113,000).

The Acquisition enhances First Derivatives presence in its largest market and will help accelerate the Company's expansion into the US by enhancing its global support offering. MRP will also provide another channel to market, for the Company's products, not only to the financial sector but also to other market segments.

The Consideration Shares will rank pari passu with the Company's existing ordinary shares. Application will be made for the Consideration Shares to be admitted to trading on AIM and the IEX and dealings are expected to commence on 19 September 2008. Following Admission the enlarged issued share capital of the Company will be 13,720,468 Ordinary Shares.

First Derivatives' CEO Brian Conlon said: "MRP is one of the leaders in its field and the continuing loyalty of its customer base, which is a roll call of the world's leading technology firms, is testimony to the quality of service it provides. This transaction represents a coming together of two very like minded firms with a mutual emphasis on professionalism and customer-driven innovation.

This Acquisition gives us access to an established team of world class technology marketing professionals. We have invested significant resources in R&D and this accelerates our channel to market particularly in the U.S. and into sectors other than investment banking. The investment will also provide a springboard for establishing a greater presence in the US market and will enable us to replicate our successful nearshore model in North America"

Kevin Cunningham of MRP said "We are excited about the opportunities that this transaction provides for MRP, our clients, and our employees. It allows us to accelerate the build out of our technology infrastructure and analytic capabilities, giving us the operational scale to meet our increasingly complex client needs. It also enables us to expand further our European operations and expertise in the financial technology sector, opening up new, more diverse business opportunities for MRP."

Contact:

First Derivatives plc

Brian Conlon

Michael O'Neill

Tel: +44 (0)28 3025 2242

Charles Stanley Securities

Nominated Adviser

Russell Cook/Carl Holmes

Tel: +44 (0)20 7149 6000

Goodbody Corporate Finance 

IEX Adviser

Finbarr Griffin/ Diane Hodgson

Tel: +353 1 667 0420

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQGUUPWBUPRGAC
Date   Source Headline
30th Sep 20191:20 pmRNSTotal Voting Rights
9th Sep 20197:00 amRNSEuronext Growth Dublin Notice
3rd Sep 20194:09 pmRNSIssue of Equity
2nd Sep 20194:35 pmRNSHolding(s) in Company
1st Aug 20198:01 amRNSTotal Voting Rights
1st Aug 20197:00 amRNSEuronext Growth Dublin Notice
31st Jul 20197:38 amRNSHolding(s) in Company
29th Jul 20197:00 amRNSStatement regarding Brian Conlon
26th Jul 20193:24 pmRNSIssue of Equity
19th Jul 201912:00 pmRNSHolding(s) in Company
9th Jul 20198:03 amRNSAdmission of Shares
9th Jul 20197:00 amRNSEuronext Growth Dublin Notice
8th Jul 20194:31 pmRNSHolding(s) in Company
5th Jul 20195:31 pmRNSHolding(s) in Company
3rd Jul 20197:00 amRNSIssue of Equity
2nd Jul 20195:42 pmRNSProposed Secondary Placing
28th Jun 20191:10 pmRNSHolding(s) in Company
27th Jun 20193:48 pmRNSAGM Statement
18th Jun 20197:00 amRNSAcquisition of minority interest in Kx Systems
4th Jun 20194:11 pmRNSNotice of AGM
31st May 20193:35 pmRNSTotal Voting Rights
31st May 20197:00 amRNSEuronext Growth Dublin Notice
24th May 20196:19 pmRNSIssue of Equity
21st May 20197:00 amRNSFull year results for the year ended 28 Feb 2019
17th May 20197:00 amRNSStatement regarding Brian Conlon
18th Apr 20197:00 amRNSTrading Statement and Notice of Results
29th Mar 20192:29 pmRNSTotal Voting Rights
20th Mar 20197:00 amRNSEuronext Growth Dublin Notice
13th Mar 20194:52 pmRNSIssue of Equity
12th Feb 20194:05 pmRNSHolding(s) in Company
7th Feb 20197:00 amRNSCapital Markets Day
6th Feb 20197:00 amRNSExtended Bank Facilities on Improved Terms
31st Jan 201911:00 amRNSTotal Voting Rights
9th Jan 20197:00 amRNSNotice of Capital Markets Day
21st Dec 20185:07 pmRNSIssue of Equity
6th Nov 20187:00 amRNSInterim Results
17th Oct 20187:00 amRNSOEM agreement with BISTel
11th Oct 20187:00 amRNSNotice of Results
28th Sep 20183:31 pmRNSTotal Voting Rights
7th Sep 20188:00 amRNSEnterprise Securities Market Notice
31st Aug 20183:26 pmRNSIssue of Equity
31st Aug 20189:03 amRNSTotal Voting Rights
10th Aug 20187:00 amRNSEnterprise Securities Market Notice
3rd Aug 20184:14 pmRNSIssue of Equity
31st Jul 201811:07 amRNSTotal Voting Rights
31st Jul 201811:02 amRNSTotal Voting Rights
16th Jul 20187:00 amRNSEuropean Energy Market Contract Win
12th Jul 20187:00 amRNSEnterprise Securities Market Notice
9th Jul 20185:50 pmRNSHolding(s) in Company
6th Jul 20185:03 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.